Pfizer's newer drugs pushed earnings past Wall Street expectations
Quartz
—
Revenue reached $14.45 billion, up 5% year-over-year, as oncology and other recently launched products offset steep declines in COVID products
Pfizer beats Q1 earnings estimates
- Pfizer Posts Better-Than-Expected Revenue, Profit Wall Street Journal —
- Pfizer Revenue Rises But Profit Falls Amid Boosted R&D Spending Wall Street Journal —
- Pfizer tops Wall Street estimates, reaffirms outlook as newer products show growth CNBC —
- Earnings Snapshot: Pfizer beats Q1 estimates but misses guidance Seeking Alpha —
- Pfizer in charts: Specialty Care, Oncology and Biosimilars drive Q1 growth, offsetting Primary Care decline Seeking Alpha —